Nanomedicine Innovation Network
The Precision NanoSystems Global




“Shaping the Future”
November 2018
Strathclyde | UK
Thursday, November 1st 2018
Strathclyde Institute of Pharmacy and Biomedical Sciences | University of Strathclyde
Strathclyde Institute of Pharmacy and Biomedical Sciences

Pieter R. Cullis, Ph.D.

Director, Life Sciences Institute, University of British Columbia; Co-Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology, Director, NanoMedicines Research Group, UBC


As author of The Personalized Medicine Revolution and co-founder of The Personalized Medicine Initiative, a not-for-profit organization introducing the framework and technologies to support personalized health, Pieter has been influential in driving personalized medicine solutions to the front lines of healthcare. Pieter has also been involved in the development of several life sciences companies including co-founding Lipex Biomembranes Inc., Tekmira Pharmaceuticals, Northern Lipids Inc., and, most recently, Acuitas Therapeutics and Precision NanoSystems. In addition, he co-founded and was Scientific Director of the Centre for Drug Research and Development (CDRD) 2004-2010. His research leadership has led to fundamental advances in the generation, loading and targeting of lipid nanoparticle (LNP) systems for intravenous delivery of small molecule drugs and macromolecular drugs such as small interfering RNA (siRNA). This work has contributed to three LNP products that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications. Pieter has published over 300 scientific articles and is an inventor on more than 40 patents. He completed his PhD in Physics at UBC and pursued postdoctoral training at the University of Oxford and the University of Utrecht.

Yvonne Perrie, Ph.D.

Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland


In 1998 she gained her PhD from the University of London investigating the role of liposomes for drug delivery. Yvonne then worked in London within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology prior to moving into Academia to set up her own research group. Yvonne joined Aston University in 2000 and was appointed Professor in Drug Delivery in 2007. In 2016, Yvonne moved to the University of Strathclyde as Professor in Drug Delivery as part of the Global Talent Appointment Programme. Yvonne’s research is multi-disciplinary and is focused on the development of drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. Yvonne’s research and academic leadership has been recognised via a range of fellowships and awards including 50th Anniversary Chair in Drug Delivery (2016), membership of the Controlled Release Society College of Fellows (2015), Fellow of the Royal Pharmaceutical Society (2014), Fellow of the Royal Society of Biology (2012), Eminent Fellow of the Academy of Pharmaceutical Sciences (2012), the Royal Pharmaceutical Society Pharmaceutical Scientist of the Year (2012), the British Science Festival Collaboration in Formulation Award (2011) and the Royal Pharmaceutical Society Science Conference Medal (2007).

Strathclyde Nanomedicine Innovation Network Schedule





Hands-On Experiments
The workshop will consist of speaker presentations, a networking lunch and a wet lab demonstration with the complete Nanoassmblr platform. Our goal is to is to provide an overview of the latest research and developments and highlight the remarkable work happening to foster learning and inspiration.

The Strathclyde location is one of five global Nanomedicine Innovation Network labs that will be conducting workshops and onsite demos. We've had an additional 25 RSVP outside of the University. The morning sessions will be lived streamed and recorded for future webinars.